Cade M, Munoz-Garcia J, Babuty A, Pare L, Cochonneau D, Fekir K
Cell Mol Life Sci. 2022; 79(3):145.
PMID: 35190870
PMC: 11072670.
DOI: 10.1007/s00018-022-04178-5.
Hayakawa M, Sakata A, Hayakawa H, Matsumoto H, Hiramoto T, Kashiwakura Y
Sci Rep. 2021; 11(1):14824.
PMID: 34290295
PMC: 8295325.
DOI: 10.1038/s41598-021-94307-0.
Pradhan-Sundd T, Gudapati S, Kaminski T, Ragni M
Cell Mol Gastroenterol Hepatol. 2021; 12(3):1061-1072.
PMID: 33705963
PMC: 8342958.
DOI: 10.1016/j.jcmgh.2021.02.014.
Merlin S, Fama R, Borroni E, Zanolini D, Bruscaggin V, Zucchelli S
Blood Adv. 2019; 3(5):825-838.
PMID: 30862611
PMC: 6418497.
DOI: 10.1182/bloodadvances.2018027979.
Merlin S, Cannizzo E, Borroni E, Bruscaggin V, Schinco P, Tulalamba W
Mol Ther. 2017; 25(8):1815-1830.
PMID: 28552407
PMC: 5542771.
DOI: 10.1016/j.ymthe.2017.04.029.
Endothelial cell control of thrombosis.
Yau J, Teoh H, Verma S
BMC Cardiovasc Disord. 2015; 15:130.
PMID: 26481314
PMC: 4617895.
DOI: 10.1186/s12872-015-0124-z.
The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A.
Arruda V
Haematologica. 2015; 100(7):849-50.
PMID: 26130509
PMC: 4486216.
DOI: 10.3324/haematol.2015.129858.
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A.
Zanolini D, Merlin S, Feola M, Ranaldo G, Amoruso A, Gaidano G
Haematologica. 2015; 100(7):881-92.
PMID: 25911555
PMC: 4486222.
DOI: 10.3324/haematol.2014.123117.
Gene therapy for hemophilia.
Rogers G, Herzog R
Front Biosci (Landmark Ed). 2015; 20(3):556-603.
PMID: 25553466
PMC: 4476626.
DOI: 10.2741/4324.
Progress and challenges in the development of a cell-based therapy for hemophilia A.
Fomin M, Togarrati P, Muench M
J Thromb Haemost. 2014; 12(12):1954-65.
PMID: 25297648
PMC: 4388483.
DOI: 10.1111/jth.12750.
Murine coagulation factor VIII is synthesized in endothelial cells.
Everett L, Cleuren A, Khoriaty R, Ginsburg D
Blood. 2014; 123(24):3697-705.
PMID: 24719406
PMC: 4055920.
DOI: 10.1182/blood-2014-02-554501.
Mesenchymal stem cells contribute to endogenous FVIII:c production.
Sanada C, Kuo C, Colletti E, Soland M, Mokhtari S, Knovich M
J Cell Physiol. 2012; 228(5):1010-6.
PMID: 23042590
PMC: 3954540.
DOI: 10.1002/jcp.24247.
Role of bone marrow transplantation for correcting hemophilia A in mice.
Follenzi A, Raut S, Merlin S, Sarkar R, Gupta S
Blood. 2012; 119(23):5532-42.
PMID: 22368271
PMC: 3369687.
DOI: 10.1182/blood-2011-07-367680.
Animal models of hemophilia.
Sabatino D, Nichols T, Merricks E, Bellinger D, Herzog R, Monahan P
Prog Mol Biol Transl Sci. 2011; 105:151-209.
PMID: 22137432
PMC: 3713797.
DOI: 10.1016/B978-0-12-394596-9.00006-8.
Alternative strategies for gene therapy of hemophilia.
Montgomery R, Shi Q
Hematology Am Soc Hematol Educ Program. 2011; 2010:197-202.
PMID: 21239794
PMC: 3383974.
DOI: 10.1182/asheducation-2010.1.197.
Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertension.
Shovlin C, Angus G, Manning R, Okoli G, Govani F, Elderfield K
PLoS One. 2010; 5(2):e9154.
PMID: 20174619
PMC: 2823490.
DOI: 10.1371/journal.pone.0009154.
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
Nichols T, Dillow A, Franck H, Merricks E, Raymer R, Bellinger D
ILAR J. 2009; 50(2):144-67.
PMID: 19293459
PMC: 3101868.
DOI: 10.1093/ilar.50.2.144.
Intracellular trafficking of factor VIII to von Willebrand factor storage granules.
Rosenberg J, Foster P, Kaufman R, Vokac E, Moussalli M, Kroner P
J Clin Invest. 1998; 101(3):613-24.
PMID: 9449695
PMC: 508605.
DOI: 10.1172/JCI1250.
The value of animal models.
Jones T
Am J Pathol. 1980; 101(3 Suppl):S3-9.
PMID: 7006406
PMC: 1903644.
Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue.
Groth C, Hathaway W, Gustafsson A, Geis W, Putnam C, Bjorken C
Surgery. 1974; 75(5):725-33.
PMID: 4824431
PMC: 2953375.
